ICON PLC (ICLR)

Market Cap	26.32B
Revenue (ttm)	8.23B
Net Income (ttm)	683.12M
Shares Out	82.68M
EPS (ttm)	8.23
PE Ratio	38.46
Forward PE	20.58
Dividend	n/a
Ex-Dividend Date	n/a

Volume	621,109
Open	315.03
Previous Close	316.51
Day's Range	315.03 - 319.04
52-Week Range	221.20 - 344.77
Beta	1.24
Analysts	Strong Buy
Price Target	345.30 (+8.48%)
Earnings Date	Jul 24, 2024

About ICLR

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also offers clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient a...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: May 15, 1998
• Employees: 41,100
• Stock Exchange: NASDAQ
• Ticker Symbol: ICLR

Financial Performance

In 2023, ICON PLC's revenue was $8.12 billion, an increase of 4.89% compared to the previous year's $7.74 billion. Earnings were $612.34 million, an increase of 21.18%.

Analyst Forecast

According to 10 analysts, the average rating for ICLR stock is "Strong Buy." The 12-month stock price forecast is $345.3, which is an increase of 8.48% from the latest price.

Price Target

$345.3

(8.48% upside)

Analyst Consensus: Strong Buy